CASE REPORTTreatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin
REFERENCES (38)
- et al.
Churg-Strauss syndrome
Ann Allergy Asthma Immunol.
(2001) - et al.
Neurological manifestations of Churg-Strauss syndrome
Mayo Clin Proc.
(1995) - et al.
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
Lancet.
(1981) - et al.
Treatment of systemic vasculitis with pooled intravenous immunoglobulin
Lancet.
(1991) - et al.
Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin
J Allergy Clin Immunol.
(1991) - et al.
Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography, part II: clinical studies
Mayo Clin Proc.
(1989) Systemic activation of basophils and eosinophils: markers and consequences
J Allergy Clin Immunol.
(2000)- et al.
Procedural guidelines for performing immunophenotyping by flow cytometry
Clin Immunol Im-munopathol.
(1989) - et al.
In vivo expression of CD69 on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils
J Allergy Clin Immunol.
(1992) - et al.
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients
Medicine.
(1996)
Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients
Arthritis Rheum.
(2001)
Clinicopathological features of Churg-Strauss syndrome-associated neuropathy
Brain.
(1999)
Cardiac involvement in Churg-Strauss syndrome: a follow-up of three cases
Eur Heart J.
(1993)
Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients
Medicine.
(1999)
Treatment of Guillain-Barre syndrome with high-dose gammaglobulin
Neurology.
(1988)
High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy
Neurology.
(1989)
Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study
Neurology.
(1994)
New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy
Clin Exp Immunol.
(1996)
Asthma and vasculitis: response to intravenous immunoglobulins
Allergol Immunopathol.
(1993)
Cited by (115)
Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis
2024, Respiratory Medicine Case ReportsMonocentric study of IL-5 monoclonal antibody induction therapy for eosinophilic granulomatosis with polyangiitis
2024, Journal of the Formosan Medical AssociationIntravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions
2023, Journal of Allergy and Clinical Immunology: In PracticeTreatment and Management of Autoimmune Neuropathies
2021, Neuromuscular Disorders: Treatment and ManagementANCA associated vasculitis
2020, European Journal of Internal MedicineGranulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG)
2020, Pharmacological Research
Copyright © 2004 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.